1,062
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Alpha1-antitrypsin impacts innate host–pathogen interactions with Candida albicans by stimulating fungal filamentation

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Article: 2333367 | Received 16 Oct 2023, Accepted 08 Mar 2024, Published online: 10 Apr 2024
 

ABSTRACT

Our immune system possesses sophisticated mechanisms to cope with invading microorganisms, while pathogens evolve strategies to deal with threats imposed by host immunity. Human plasma protein α1-antitrypsin (AAT) exhibits pleiotropic immune-modulating properties by both preventing immunopathology and improving antimicrobial host defence. Genetic associations suggested a role for AAT in candidemia, the most frequent fungal blood stream infection in intensive care units, yet little is known about how AAT influences interactions between Candida albicans and the immune system. Here, we show that AAT differentially impacts fungal killing by innate phagocytes. We observed that AAT induces fungal transcriptional reprogramming, associated with cell wall remodelling and downregulation of filamentation repressors. At low concentrations, the cell-wall remodelling induced by AAT increased immunogenic β-glucan exposure and consequently improved fungal clearance by monocytes. Contrastingly, higher AAT concentrations led to excessive C. albicans filamentation and thus promoted fungal immune escape from monocytes and macrophages. This underscores that fungal adaptations to the host protein AAT can differentially define the outcome of encounters with innate immune cells, either contributing to improved immune recognition or fungal immune escape.

Acknowledgements

We acknowledge Sascha Brunke for assistance with microarray analysis. We thank Christoph Becker for the kind provision of Gsdmd-/- mice. We acknowledge Ceren Oktay and Kira Skurk for research support.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data Availability statement

All metadata to replicate the findings of this study are provided in the methods, and data will be made available upon request unless this compromises blood donor anonymity. The microarray dataset generated in this study has been deposited in GEO Series accession number GSE165326 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165326).

Author contributions

MJ: Conceptualization, Formal analysis, Investigation, Writing – Original Draft, Visualization AD: Validation, Formal analysis, Investigation, Writing – Original Draft, Visualization SA: Validation, Investigation, Visualization SD: Investigation PP: Investigation LV: Resources RJAM: Investigation EGGS: Investigation JR: Resources SW: Resources TA: Investigation, Validation, Writing – Review & Editing LABJ: Conceptualization, Methodology, Resources, Writing – Review & Editing, Supervision BH: Methodology, Resources, Writing – Review & Editing, Supervision MGN: Conceptualization, Methodology, Resources, Writing – Review & Editing, Supervision CAD: Conceptualization, Methodology, Resources, Writing – Original Draft, Supervision, Project administration MSG: Conceptualization, Formal analysis, Investigation, Writing – Original Draft, Visualization, Supervision, Project administration, Funding acquisition

Supplementary material

Supplemental data for this article can be accessed online at https://doi.org/10.1080/21505594.2024.2333367

Additional information

Funding

MSG and AD were supported by a grant in the Deutsche Forschungsgemeinschaft (DFG) Emmy Noether Program (project no. 434385622/GR 5617/1-1) to MSG. MSG was further supported by a Research Grant 2019 from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and an Alexander von Humboldt postdoctoral fellowship. MGN was supported by an ERC Advanced Grant (833247) and a Spinoza grant from the Netherlands Organization for Scientific Research. SA and BH were supported by funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 847507 (HDM-FUN). MJ and MSG were supported by the Interleukin Foundation. CAD was supported by a NIH grant (AI 15614). JR was supported by a DFG grant (RU 695/12-1) and an ERC Horizon 2020 research grant (grant agreement No 834154).